Response Oncology Stock Cash And Equivalents
Response Oncology fundamentals help investors to digest information that contributes to Response Oncology's financial success or failures. It also enables traders to predict the movement of Response Stock. The fundamental analysis module provides a way to measure Response Oncology's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Response Oncology stock.
Response |
Response Oncology Company Cash And Equivalents Analysis
Response Oncology's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Current Response Oncology Cash And Equivalents | 9.01 M |
Most of Response Oncology's fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Response Oncology is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
CompetitionIn accordance with the recently published financial statements, Response Oncology has 9.01 M in Cash And Equivalents. This is much higher than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The cash and equivalents for all United States stocks is notably lower than that of the firm.
Response Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Response Oncology's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Response Oncology could also be used in its relative valuation, which is a method of valuing Response Oncology by comparing valuation metrics of similar companies.Response Oncology is currently under evaluation in cash and equivalents category among its peers.
Response Fundamentals
Return On Equity | -7.24 | |||
Return On Asset | -0.0153 | |||
Profit Margin | (0.47) % | |||
Operating Margin | (0.01) % | |||
Current Valuation | 16.62 M | |||
Shares Outstanding | 12.18 M | |||
Revenue | 118.08 M | |||
Gross Profit | 28.17 M | |||
EBITDA | 1.32 M | |||
Net Income | (51.39 M) | |||
Cash And Equivalents | 9.01 M | |||
Cash Per Share | 0.74 X | |||
Total Debt | 26.45 M | |||
Current Ratio | 13.35 X | |||
Book Value Per Share | (1.54) X | |||
Cash Flow From Operations | 9.1 M | |||
Earnings Per Share | (4.16) X | |||
Number Of Employees | 10 | |||
Beta | -19.24 | |||
Market Capitalization | 12 | |||
Total Asset | 28.9 M | |||
Retained Earnings | (120.16 M) | |||
Working Capital | 34.72 M | |||
Current Asset | 37.25 M | |||
Current Liabilities | 2.54 M | |||
Z Score | -0.15 | |||
Net Asset | 28.9 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Consideration for investing in Response Stock
If you are still planning to invest in Response Oncology check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Response Oncology's history and understand the potential risks before investing.
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Stocks Directory Find actively traded stocks across global markets | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Commodity Directory Find actively traded commodities issued by global exchanges |